Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitasha Rupani

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
JMIR Research Protocols|March 19, 2019
Modern Innovative Solutions to Improve Outcomes in Asthma, Breathlessness, and Chronic Obstructive Pulmonary Disease (MISSION ABC): Protocol for a Mixed-Methods StudyEleanor Lanning, Emily Heiden, Jayne Longstaff, et al.
Journal of Medical Internet Research|November 12, 2020
Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods StudyRoma Maguire, John Connaghan, Anne Arber, et al.
American Journal of Respiratory and Critical Care Medicine|January 28, 2016
Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA ProfileHitasha Rupani, Rocio T Martinez-Nunez, Patrick Dennison, et al.
Plos One|November 1, 2014
A microRNA network dysregulated in asthma controls IL-6 production in bronchial epithelial cellsRocio T Martinez-Nunez, Victor P Bondanese, Fethi Louafi, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Impact of comorbidities on EQ-5D quality-of-life index in severe asthmaPaul E Pfeffer, Thomas Brown, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 28, 2023
Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low StatusHitasha Rupani, Mohammed Aref Kyyaly, Adnan Azim, et al.
JMIR Research Protocols|May 26, 2018
Exploring the Waveform Characteristics of Tidal Breathing Carbon Dioxide, Measured Using the N-Tidal C Device in Different Breathing Conditions (The General Breathing Record Study): Protocol for an Observational, Longitudinal StudyDaniel M Neville, Hitasha Rupani, Paul R Kalra, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
Tissue Barriers|September 2, 2016
IL-1α mediates cellular cross-talk in the airway epithelial mesenchymal trophic unitAlison R Hill, Jessica E Donaldson, Cornelia Blume, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
JMIR Research Protocols|March 19, 2019
Modern Innovative Solutions to Improve Outcomes in Asthma, Breathlessness, and Chronic Obstructive Pulmonary Disease (MISSION ABC): Protocol for a Mixed-Methods StudyEleanor Lanning, Emily Heiden, Jayne Longstaff, et al.
Journal of Medical Internet Research|November 12, 2020
Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods StudyRoma Maguire, John Connaghan, Anne Arber, et al.
American Journal of Respiratory and Critical Care Medicine|January 28, 2016
Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA ProfileHitasha Rupani, Rocio T Martinez-Nunez, Patrick Dennison, et al.
Plos One|November 1, 2014
A microRNA network dysregulated in asthma controls IL-6 production in bronchial epithelial cellsRocio T Martinez-Nunez, Victor P Bondanese, Fethi Louafi, et al.
ERJ Open Research|January 21, 2026
Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma RegistryPaul E Pfeffer, Jola Karaj, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Impact of comorbidities on EQ-5D quality-of-life index in severe asthmaPaul E Pfeffer, Thomas Brown, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 28, 2023
Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low StatusHitasha Rupani, Mohammed Aref Kyyaly, Adnan Azim, et al.
JMIR Research Protocols|May 26, 2018
Exploring the Waveform Characteristics of Tidal Breathing Carbon Dioxide, Measured Using the N-Tidal C Device in Different Breathing Conditions (The General Breathing Record Study): Protocol for an Observational, Longitudinal StudyDaniel M Neville, Hitasha Rupani, Paul R Kalra, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
Tissue Barriers|September 2, 2016
IL-1α mediates cellular cross-talk in the airway epithelial mesenchymal trophic unitAlison R Hill, Jessica E Donaldson, Cornelia Blume, et al.
Pageof 5